Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125432922 | 12543292 | 2 | F | 20160808 | 20160711 | 20160815 | EXP | CA-TEVA-675196USA | TEVA | FRALICK M, JUURLINK DN, MARRAS T. BLEEDING ASSOCIATED WITH COADMINISTRATION OF RIVAROXABAN AND CLARITHROMYCIN.CMAJ. 2016; 188(9):669-672 | 65.00 | YR | M | Y | 0.00000 | 20160815 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125432922 | 12543292 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Y | 65154 | 500 | MG | BID | ||||||||
| 125432922 | 12543292 | 2 | I | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Y | 65154 | 500 | MG | BID | ||||||||
| 125432922 | 12543292 | 3 | I | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Y | 65154 | 500 | MG | BID | ||||||||
| 125432922 | 12543292 | 4 | I | RIVAROXABAN | RIVAROXABAN | 1 | Y | U | 0 | 20 | MG | ||||||||
| 125432922 | 12543292 | 5 | C | TRIMETHOPRIM. | TRIMETHOPRIM | 1 | DOUBLE-STRENGTH | 0 | QOD | ||||||||||
| 125432922 | 12543292 | 6 | C | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 0 | 650 | MG | |||||||||
| 125432922 | 12543292 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 0 | 5 | MG | ||||||||||
| 125432922 | 12543292 | 8 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | 40 | MG | ||||||||||
| 125432922 | 12543292 | 9 | C | TIOTROPIUM | TIOTROPIUM | 1 | 0 | 18 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125432922 | 12543292 | 1 | Oropharyngeal pain |
| 125432922 | 12543292 | 2 | Dyspnoea |
| 125432922 | 12543292 | 3 | Cough |
| 125432922 | 12543292 | 5 | Antifungal prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125432922 | 12543292 | HO |
| 125432922 | 12543292 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125432922 | 12543292 | Drug interaction | |
| 125432922 | 12543292 | Epistaxis | |
| 125432922 | 12543292 | Haemoptysis | |
| 125432922 | 12543292 | Haemorrhage intracranial | |
| 125432922 | 12543292 | Headache | |
| 125432922 | 12543292 | Pulmonary haemorrhage | |
| 125432922 | 12543292 | Self-medication | |
| 125432922 | 12543292 | Subarachnoid haemorrhage | |
| 125432922 | 12543292 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |